These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1525059)

  • 1. Tamoxifen induced changes in MCF7 human breast cancer: in vitro and in vivo studies using nuclear magnetic resonance spectroscopy and imaging.
    Furman E; Rushkin E; Margalit R; Bendel P; Degani H
    J Steroid Biochem Mol Biol; 1992 Sep; 43(1-3):189-95. PubMed ID: 1525059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo studies by magnetic resonance imaging and spectroscopy of the response to tamoxifen of MCF7 human breast cancer implanted in nude mice.
    Furman E; Margalit R; Bendel P; Horowitz A; Degani H
    Cancer Commun; 1991 Sep; 3(9):287-97. PubMed ID: 1911045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic studies of estrogen- and tamoxifen-treated human breast cancer cells by nuclear magnetic resonance spectroscopy.
    Neeman M; Degani H
    Cancer Res; 1989 Feb; 49(3):589-94. PubMed ID: 2562927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycolysis and glucose transporter 1 as markers of response to hormonal therapy in breast cancer.
    Rivenzon-Segal D; Boldin-Adamsky S; Seger D; Seger R; Degani H
    Int J Cancer; 2003 Nov; 107(2):177-82. PubMed ID: 12949791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance imaging and spectroscopy of MCF7 human breast cancer: pathophysiology and monitoring of treatment.
    Degani H; Furman E; Fields S
    Clin Chim Acta; 1994 Jul; 228(1):19-33. PubMed ID: 7955426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tamoxifen enhances cell death in implanted MCF7 breast cancer by inhibiting endothelium growth.
    Haran EF; Maretzek AF; Goldberg I; Horowitz A; Degani H
    Cancer Res; 1994 Nov; 54(21):5511-4. PubMed ID: 7923186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early estrogen-induced metabolic changes and their inhibition by actinomycin D and cycloheximide in human breast cancer cells: 31P and 13C NMR studies.
    Neeman M; Degani H
    Proc Natl Acad Sci U S A; 1989 Jul; 86(14):5585-9. PubMed ID: 2748604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MCF7/LCC9: an antiestrogen-resistant MCF-7 variant in which acquired resistance to the steroidal antiestrogen ICI 182,780 confers an early cross-resistance to the nonsteroidal antiestrogen tamoxifen.
    Brünner N; Boysen B; Jirus S; Skaar TC; Holst-Hansen C; Lippman J; Frandsen T; Spang-Thomsen M; Fuqua SA; Clarke R
    Cancer Res; 1997 Aug; 57(16):3486-93. PubMed ID: 9270017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of tamoxifen resistance of human breast carcinomas in vivo by neutralizing antibodies to transforming growth factor-beta.
    Arteaga CL; Koli KM; Dugger TC; Clarke R
    J Natl Cancer Inst; 1999 Jan; 91(1):46-53. PubMed ID: 9890169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth inhibition in response to estrogen withdrawal and tamoxifen therapy of human breast cancer xenografts evaluated by in vivo 31P magnetic resonance spectroscopy, creatine kinase activity, and apoptotic index.
    Kristensen CA; Kristjansen PE; Brünner N; Quistorff B; Spang-Thomsen M
    Cancer Res; 1995 Sep; 55(18):4146-50. PubMed ID: 7664292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiogenic response of MCF7 human breast cancer to hormonal treatment: assessment by dynamic GdDTPA-enhanced MRI at high spatial resolution.
    Furman-Haran E; Margalit R; Maretzek AF; Degani H
    J Magn Reson Imaging; 1996; 6(1):195-202. PubMed ID: 8851428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormone dependence of breast cancer cells and the effects of tamoxifen and estrogen: 31P NMR studies.
    Ruiz-Cabello J; Berghmans K; Kaplan O; Lippman ME; Clarke R; Cohen JS
    Breast Cancer Res Treat; 1995 Mar; 33(3):209-17. PubMed ID: 7749148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormonally induced modulation in the phosphate metabolites of breast cancer: analysis of in vivo 31P MRS signals with a modified prony method.
    Viti V; Ragona R; Guidoni L; Barone P; Furman E; Degani H
    Magn Reson Med; 1997 Aug; 38(2):285-95. PubMed ID: 9256110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of the mechanism of tamoxifen-stimulated breast tumor growth with nonisomerizable analogues of tamoxifen and metabolites.
    Wolf DM; Langan-Fahey SM; Parker CJ; McCague R; Jordan VC
    J Natl Cancer Inst; 1993 May; 85(10):806-12. PubMed ID: 8487325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of estrogens and antiestrogens on growth of human breast cancer cells in athymic nude mice.
    Osborne CK; Hobbs K; Clark GM
    Cancer Res; 1985 Feb; 45(2):584-90. PubMed ID: 3967234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 31P-nuclear magnetic resonance spectroscopy in vivo of six human melanoma xenograft lines: tumour bioenergetic status and blood supply.
    Lyng H; Olsen DR; Southon TE; Rofstad EK
    Br J Cancer; 1993 Dec; 68(6):1061-70. PubMed ID: 8260356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrasting actions of tamoxifen on endometrial and breast tumor growth in the athymic mouse.
    Gottardis MM; Robinson SP; Satyaswaroop PG; Jordan VC
    Cancer Res; 1988 Feb; 48(4):812-5. PubMed ID: 3338079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the effects of a pure steroidal antiestrogen with those of tamoxifen in a model of human breast cancer.
    Osborne CK; Coronado-Heinsohn EB; Hilsenbeck SG; McCue BL; Wakeling AE; McClelland RA; Manning DL; Nicholson RI
    J Natl Cancer Inst; 1995 May; 87(10):746-50. PubMed ID: 7563152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect on growth and cell cycle kinetics of estradiol and tamoxifen on MCF-7 human breast cancer cells grown in vitro and in nude mice.
    Brünner N; Bronzert D; Vindeløv LL; Rygaard K; Spang-Thomsen M; Lippman ME
    Cancer Res; 1989 Mar; 49(6):1515-20. PubMed ID: 2924304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 31P-nuclear magnetic resonance spectroscopy in vivo of four human melanoma xenograft lines: spin-lattice relaxation times.
    Olsen DR; Lyng H; Southon TE; Rofstad EK
    Radiother Oncol; 1994 Jul; 32(1):54-62. PubMed ID: 7938679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.